Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026)
Neogen (NEOG) posted quarterly Liabilities from Discontinued Operations of 6600000.0 for Q2 2026, little changed year-over-year from 6600000.0 in Q2 2025, and up 3.12% quarter-over-quarter from 6400000.0 in Q1 2026.
Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026) Analysis & Trends
Neogen's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 6600000.0 for Q2 2026.
- In Q2 2026, Liabilities from Discontinued Operations changed 0.0% year-over-year to 6600000.0; the TTM figure through May 2026 stood at 6600000.0 (changed 0.0% YoY), while the FY2026 annual figure was 6600000.0, changed 0.0% from the prior year.
- Liabilities from Discontinued Operations for Q2 2026 stood at 6600000.0, up from 6400000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 9107000.0 in Q4 2025, with the low at 6400000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 6.60 Mn |
| May 31, 2026 | 6.60 Mn |
| Feb 28, 2026 | 6.40 Mn |
| Feb 28, 2026 | 6.40 Mn |
| Nov 30, 2025 | 9.11 Mn |
| Nov 30, 2025 | 9.11 Mn |
| May 31, 2025 | 6.60 Mn |
| May 31, 2025 | 6.60 Mn |